• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Akouos, Inc. - Common Stock (NQ:AKUS)

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Nov 30, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Akouos, Inc. - Common Stock

< Previous 1 2 Next >
News headline image
Around $375 Million Bet On This Biotechnology Stock? Check Out These 4 Stocks Insiders Are Buying ↗
December 02, 2022
Although US stocks closed mixed on Thursday, there were a few notable insider trades. 
Via Benzinga
News headline image
Why Quoin Pharmaceuticals Shares Jumped By More Than 44%; Here Are 57 Biggest Movers From Yesterday ↗
October 19, 2022
Gainers COMSovereign Holding Corp. (NASDAQ: COMS) shares jumped 170.1% to close at $0.1194 on Tuesday after gaining 4% on Monday. 
Via Benzinga
News headline image
Carnival, Amazon, Iamgold And Other Big Gainers From Tuesday ↗
October 19, 2022
U.S. stocks closed higher on Monday, with the Dow Jones gaining more than 300 points. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
News headline image
Why Is Akouos (AKUS) Stock Up 85% Today? ↗
October 18, 2022
As a pharmaceutical giant seeks to delve deeper into gene therapy, today's merger announcement has AKUS stock traders in a frenzy. 
Via InvestorPlace
News headline image
Why Akouos Stock Is on Fire Today ↗
October 18, 2022
A buyout agreement is lighting a fire underneath the biotech's shares today. 
Via The Motley Fool
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2022 ↗
October 19, 2022
Upgrades 
Via Benzinga
News headline image
FDA Clears Akouos' Gene Therapy Trial For Genetic Form Of Hearing Loss ↗
September 13, 2022
 
Via Benzinga
News headline image
AKOUOS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akouos, Inc. - AKUS
October 18, 2022
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Crude Oil Drops Over 2%; Akouos Shares Spike Higher ↗
October 18, 2022
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 300 points on Tuesday. 
Via Benzinga
News headline image
Wall Street Extends Lead After Strong Earnings ↗
October 18, 2022
Wall Street is building on yesterday's rally, with the Dow Jones Industrial Average boasting a more than 200-point lead after an impressive round of bank earnings. 
Via Talk Markets
News headline image
Nasdaq Rises Over 100 Points; Goldman Sachs Tops Q3 Views ↗
October 18, 2022
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 100 points on Tuesday. 
Via Benzinga
News headline image
Akouos: Q2 Earnings Insights ↗
August 15, 2022
  Akouos (NASDAQ:AKUS) reported its Q2 earnings results on Monday, August 15, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Why Akouos Shares Are Trading Sharply Higher? Here Are 36 Stocks Moving In Tuesday's Mid-Day Session ↗
October 18, 2022
Gainers 
Via Benzinga
News headline image
Akouos (NASDAQ: AKUS) Enters Into Agreement to be Acquired by Eli Lilly (NYSE: LLY) at Valuation Up to $610 Million
October 18, 2022
Akouos, Inc. (NASDAQ: AKUS) is engaged as a precision genetic medicine company, which is focused on the research and development 
Via Spotlight Growth
News headline image
Zovio (ZVO) Stock Soars 90% Ahead of Oct. 25 Dissolution Vote ↗
October 18, 2022
Zovio (ZVO) stock is rocketing higher on Tuesday as investors prepare for an incredibly important vote next week! 
Via InvestorPlace
News headline image
Health Care Company Eli Lilly Announces Acquisition of Akouos ↗
October 18, 2022
Eli Lilly (NYSE:LLY) has announced an acquisition of Akouos (NASDAQ:AKUS) that is expected to be completed in Q4 of 2022. 
Via Benzinga
News headline image
US Stocks Extend Monday's Gains; Dow Jumps Over 500 Points ↗
October 18, 2022
U.S. stocks traded higher this morning, with the Dow Jones gaining over 500 points on Tuesday. The Dow also climbed around 550 points on Monday. 
Via Benzinga
News headline image
Eli Lilly Acquires Akouos For Over $450M To Accelerate Hearing Loss Gene Therapies ↗
October 18, 2022
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
October 18, 2022
Gainers Akouos (NASDAQ:AKUS) shares moved upwards by 86.2% to $13.05 during Tuesday's pre-market session. The company's market cap stands at $481.5 million. 
Via Benzinga
News headline image
AKUS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Akouos, Inc. Is Fair to Shareholders
October 18, 2022
From Halper Sadeh LLC
Via Business Wire
News headline image
AVEO Pharmaceuticals, Akouos And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗
October 18, 2022
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
News headline image
Why Senti Biosciences Shares Jumped Over 50%; Here Are 79 Biggest Movers From Yesterday ↗
September 30, 2022
Gainers Senti Biosciences, Inc. (NASDAQ: SNTI) shares climbed 50.7% to close at $2.11 on Thursday after B of A Securities initiated coverage on the stock with a Buy rating and $7 price target. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2022 ↗
September 29, 2022
Upgrades 
Via Benzinga
News headline image
Important Biotech Catalysts For September 13, 2022 - End Of The Day Summary ↗
September 13, 2022
 
Via Benzinga
News headline image
Stocks Remain Shaky Midweek, Dow Sporting Muted Gains ↗
June 29, 2022
As the first half of 2022 draws to an end, stocks continue to struggle for direction. 
Via Talk Markets
News headline image
Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday ↗
September 14, 2022
Gainers Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tuesday after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX... 
Via Benzinga
News headline image
This Financial Services Stock Surged Around 116%; Here Are 86 Biggest Movers From Yesterday ↗
August 16, 2022
Gainers Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 115.7% to close at $17.73 on volatility following the company's IPO earlier this month. 
Via Benzinga
News headline image
Tesla, Twitter And 76 Biggest Movers From Friday ↗
July 11, 2022
Gainers Seritage Growth Properties (NYSE: SRG) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board... 
Via Benzinga
News headline image
Accolade Shares Jump Around 29%, Here's 75 Biggest Movers From Friday ↗
July 05, 2022
Gainers Omeros Corporation (NASDAQ: OMER) jumped 68.7% to close at $4.64. Clovis Oncology, Inc. (NASDAQ: CLVS) gained 58.3% to settle at $2.85 on Friday. 
Via Benzinga
News headline image
This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday ↗
June 30, 2022
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares surged 114.3% to close at $0.2550 on Wednesday after the company announced it has terminated its previously announced at-the-market offering. 
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap